Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
| ▸ | MGAM | O43451 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 2/20 | 0.30 |
| ▸ | SI | P14410 | 2/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15037470 | 0.90 | APP (0.38) | APP | |
| SCHEMBL16369055 | 0.89 | LTA4H (0.42) | CYP19A1MGAMGAASIMGAM2 | |
| SCHEMBL15017930 | 0.88 | LTA4H (0.41) | CYP19A1MGAMGAASIMGAM2 | |
| SCHEMBL15017928 | 0.88 | LTA4H (0.41) | CYP19A1MGAMGAASIMGAM2 | |
| SCHEMBL15018593 | 0.86 | NR5A1 (0.46) | CYP19A1GAA | |
| SCHEMBL15018591 | 0.86 | NR5A1 (0.46) | CYP19A1GAA | |
| SCHEMBL15018842 | 0.85 | LTA4H (0.38) | CYP19A1 | |
| SCHEMBL15018839 | 0.85 | LTA4H (0.38) | CYP19A1 | |
| SCHEMBL20853536 | 0.85 | NR5A1 (0.48) | GAA | |
| SCHEMBL15037507 | 0.85 | NR5A1 (0.48) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2791250-B1 | PARTICULAR AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH COMPOUND, IMPLEMENTATION PROCESS THEREFORE AND USE THEREOF | OREAL (FR) | 2019-04-03 | — | — | EP | disclosed |
| US-9226883-B2 | Particular azomethine direct dyes, dye composition comprising at least one such compound, implementation process therefore and use thereof | L'OREAL (FR) | 2016-01-05 | — | — | US | disclosed |
| US-9226883-B2 | Particular azomethine direct dyes, dye composition comprising at least one such compound, implementation process therefore and use thereof | L'OREAL (FR) | 2016-01-05 | — | — | US | disclosed |
| US-20150000688-A1 | PARTICULAR AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH COMPOUND, IMPLEMENTATION PROCESS THEREFORE AND USE THEREOF | L'OREAL (FR) | 2015-01-01 | — | — | US | disclosed |
| US-20150000688-A1 | PARTICULAR AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH COMPOUND, IMPLEMENTATION PROCESS THEREFORE AND USE THEREOF | L'OREAL (FR) | 2015-01-01 | — | — | US | disclosed |
| WO-2013087636-A1 | PARTICULAR AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH COMPOUND, IMPLEMENTATION PROCESS THEREFORE AND USE THEREOF | L'OREAL (FR) | 2013-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150000688-A1 | PARTICULAR AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH COMPOUND, IMPLEMENTATION PROCESS THEREFORE AND USE THEREOF | KRT18, IK, MKI67 | CYP19A1 506/4885APP 834/4885MGAM 2452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.